Stereotaxis Inc (STXS) Faces Revenue Pressure Amid Strategic Transformation [Yahoo! Finance]
Stereotaxis, Inc. (STXS)
US:NASDAQ Investor Relations:
ir.stereotaxis.com
Company Research
Source: Yahoo! Finance
Gross Margin: Gross margin for 2023 stood at 56%, with recurring revenue gross margin at 79% and system revenue gross margin at 8%. Operating Loss: Operating loss for Q4 2023 was ($5.3) million, with a full year loss of ($21.8) million. Net Loss: Net loss for Q4 2023 was ($5.0) million, increasing the full year net loss to ($20.7) million. Balance Sheet: As of December 31, 2023, Stereotaxis reported cash and cash equivalents of $20.6 million with no debt. Forward-Looking Expectations: Anticipates double-digit revenue growth for 2024 with Q1 revenue guidance of approximately $7.0 million. Warning! GuruFocus has detected 5 Warning Signs with STXS. Stereotaxis Inc ( STXS ) released its 8-K filing on March 4, 2024, reporting its financial results for the fourth quarter and full year ended December 31, 2023. The company, a pioneer in robotic technologies for minimally invasive endovascular intervention, is undergoing a strategic transformation aimed at setting the stage for fu
Show less
Read more
Impact Snapshot
Event Time:
STXS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
STXS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
STXS alerts
High impacting Stereotaxis, Inc. news events
Weekly update
A roundup of the hottest topics
STXS
News
- Stereotaxis to Report First Quarter 2024 Financial Results on May 13, 2024GlobeNewswire
- Major Regulatory Approvals Coming For Stereotaxis In The Next 10 Months [Seeking Alpha]Seeking Alpha
- Stereotaxis (STXS) Seeks Clearance for MAGiC Catheter [Yahoo! Finance]Yahoo! Finance
- Stereotaxis, Inc. (AMEX:STXS) Q4 2023 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Stereotaxis Announces Regulatory Submissions of the MAGiC Ablation Catheter in Europe and the United States [Yahoo! Finance]Yahoo! Finance
STXS
Earnings
- 3/4/24 - Miss
STXS
Sec Filings
- 4/8/24 - Form DEFA14A
- 4/4/24 - Form 4
- 4/4/24 - Form DEFA14A
- STXS's page on the SEC website